galactosamine has been researched along with Adjuvant Arthritis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caneda, CD; Carson, DA; Chan, M; Corr, M; Cottam, HB; Crain, B; Hayashi, T; Yao, S | 1 |
| Abbott, C; Carmichael, D; Chan, C; Cherry, L; Cheung, P; Chirino, AJ; Chung, HH; Dahiyat, BI; Desjarlais, JR; Doberstein, SK; Eivazi, A; Filikov, AV; Gao, SX; Hubert, RS; Hwang, M; Hyun, L; Kashi, S; Kim, A; Kim, E; Kung, J; Martinez, SP; Muchhal, US; Nguyen, DH; O'Brien, C; O'Keefe, D; Singer, K; Steed, PM; Szymkowski, DE; Tansey, MG; Vafa, O; Vielmetter, J; Yoder, SC; Zalevsky, J; Zhukovsky, EA | 1 |
| Bateman-Fite, R; Brackeen, MF; Clark, RL; Connolly, KM; Menius, JA; Noel, LS; Sekut, L; Stimpson, SA; Yarnall, D | 1 |
3 other study(ies) available for galactosamine and Adjuvant Arthritis
| Article | Year |
|---|---|
Novel synthetic toll-like receptor 4/MD2 ligands attenuate sterile inflammation.
Topics: Animals; Arthritis, Experimental; Galactosamine; Hep G2 Cells; High-Throughput Screening Assays; Humans; Inflammation; Ligands; Lipopolysaccharide Receptors; Lymphocyte Antigen 96; Mice; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; Signal Transduction; Structure-Activity Relationship; Toll-Like Receptor 4 | 2014 |
Inactivation of TNF signaling by rationally designed dominant-negative TNF variants.
Topics: Amino Acid Substitution; Animals; Antigens, CD; Apoptosis; Arthritis, Experimental; Biopolymers; Caspases; Cell Line; Cell Nucleus; Computer Simulation; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Galactosamine; HeLa Cells; Humans; Liver; NF-kappa B; Point Mutation; Protein Engineering; Rats; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Signal Transduction; Transcription Factor RelA; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2003 |
Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Carrageenan; Female; Galactosamine; Inflammation; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Phosphodiesterase Inhibitors; Purinones; Pyridazines; Pyrrolidinones; Quinazolines; Rats; Rats, Inbred Lew; Rolipram; Shock, Septic; Tumor Necrosis Factor-alpha | 1995 |